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Background:  The timing of aortic valve replacement (AVR) remains controversial in symptomatic patients with low-gradient (LG) severe 
aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF). We sought to compare long-term mortality of early AVR versus a 
watchful observation strategy.
methods:  From 2000 to 2011, we prospectively evaluated 328 consecutive, symptomatic patients (162 men, age; 68±10 years) with LG 
severe AS and preserved LVEF who were potential candidates for early AVR. LG severe AS was defined as indexed aortic valve area 
(AVAi) < 0.6 cm2/m2 with mean gradient < 40 mmHg. Early AVR was performed on 121 patients within 6 months of diagnosis (group A) 
while the watchful observation strategy was selected for 207 patients (group B). Patients in the group B were referred for AVR if mean 
gradient ≥ 40 mmHg during follow-up.
results:  There were no significant differences between the two groups in terms of age, gender, LVEF, comorbidity index, Society of 
Thoracic Surgeons (STS) score and stroke volume index, but the group A had smaller AVAi and higher gradient than the group B (p < 0.05). 
During a median follow-up of 5.3 years (IQR 3.6-7.9), 19 (16%) deaths occurred in the group A and 37 (18%) deaths in the group B, and 
the risk of overall mortality was not significantly different between the two groups in the overall cohort (HR 0.90 for the early AVR; 95% CI, 
0.52 to 1.56; p = 0.71). In the group B, progression to high-gradient AS occurred to 164 patients, but 51 (31%) patients refused to undergo 
AVR. STS score, comorbidity index and performance of AVR was associated with survival on multivariable Cox analysis (p < 0.01). For 98 
propensity-score matched pairs, the risk of overall death was not significantly different between the two groups (HR 1.56 for the early AVR; 
95% CI, 0.78 to 3.12; p = 0.21), but when patients who refused to undergo AVR were censored at the time of progression to high-gradient 
AS, the early AVR group had a higher risk of overall mortality (HR 3.41; 95% CI, 1.28 to 9.03; p = 0.014).
conclusion:  The early AVR did not improve survival in symptomatic patients with LG severe AS and preserved LVEF. Watchful 
observation with timely performance of AVR should be considered a therapeutic option.
